NO20053483L - 4-Anilinokinazolinderivater for behandling av unormal cellevekst - Google Patents
4-Anilinokinazolinderivater for behandling av unormal cellevekstInfo
- Publication number
- NO20053483L NO20053483L NO20053483A NO20053483A NO20053483L NO 20053483 L NO20053483 L NO 20053483L NO 20053483 A NO20053483 A NO 20053483A NO 20053483 A NO20053483 A NO 20053483A NO 20053483 L NO20053483 L NO 20053483L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- cell growth
- abnormal cell
- treatment
- compound
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 title abstract 2
- 230000010261 cell growth Effects 0.000 title abstract 2
- MTSNDBYBIZSILH-UHFFFAOYSA-N n-phenylquinazolin-4-amine Chemical class N=1C=NC2=CC=CC=C2C=1NC1=CC=CC=C1 MTSNDBYBIZSILH-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43448602P | 2002-12-18 | 2002-12-18 | |
| PCT/IB2003/005826 WO2004054585A1 (en) | 2002-12-18 | 2003-12-08 | 4-anilino quinazoline derivatives for the treatment of abnormal cell growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053483D0 NO20053483D0 (no) | 2005-07-18 |
| NO20053483L true NO20053483L (no) | 2005-09-19 |
Family
ID=32595280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053483A NO20053483L (no) | 2002-12-18 | 2005-07-18 | 4-Anilinokinazolinderivater for behandling av unormal cellevekst |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20040254204A1 (de) |
| EP (1) | EP1575592A1 (de) |
| JP (1) | JP2006513179A (de) |
| KR (1) | KR20050085749A (de) |
| CN (1) | CN1729001A (de) |
| AR (1) | AR042480A1 (de) |
| AU (1) | AU2003303045A1 (de) |
| BR (1) | BR0317433A (de) |
| CA (1) | CA2510323A1 (de) |
| GT (1) | GT200300286A (de) |
| MX (1) | MXPA05006335A (de) |
| NL (1) | NL1025044C2 (de) |
| NO (1) | NO20053483L (de) |
| PA (1) | PA8592801A1 (de) |
| PE (1) | PE20040905A1 (de) |
| PL (1) | PL377686A1 (de) |
| RU (1) | RU2005119172A (de) |
| TW (1) | TW200424190A (de) |
| WO (1) | WO2004054585A1 (de) |
| ZA (1) | ZA200504147B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2400339T3 (es) | 2002-07-15 | 2013-04-09 | Symphony Evolution, Inc. | Compuestos, composiciones farmacéuticas de los mismos y su uso en el tratamiento del cáncer |
| KR20080014144A (ko) * | 2003-08-18 | 2008-02-13 | 화이자 프로덕츠 인크. | ｅｒｂＢ２ 항암제에 대한 투약 스케쥴 |
| CA2744997A1 (en) | 2003-09-26 | 2005-04-07 | Exelixis, Inc. | C-met modulators and method of use |
| EP1896451A2 (de) * | 2005-06-03 | 2008-03-12 | Pfizer Products Incorporated | Bicyclische derivate zur behandlung von anormalem zellwachstum |
| WO2008057280A1 (en) | 2006-10-27 | 2008-05-15 | Amgen Inc. | Multi-cyclic compounds and methods of use |
| EA038195B1 (ru) | 2009-01-16 | 2021-07-22 | Экселиксис, Инк. | Малатная соль n-(4-{[6,7-бис-(метилокси)хинолин-4-ил]окси}фенил)-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида и ее применение для лечения рака почек и печени |
| UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
| US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
| US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
| DK2621481T4 (da) | 2010-09-27 | 2023-01-09 | Exelixis Inc | Dobbelte inhibitorer af MET og VEGF til behandling af kastrationsresistent prostatacancer og osteoblastiske knoglemetastaser |
| US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0711783A1 (de) * | 1994-11-08 | 1996-05-15 | Glaxo, S.A. | Antifungale Sordarinderivate |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| SK3822002A3 (en) * | 1999-09-21 | 2002-10-08 | Astrazeneca Ab | Quinazoline derivatives, process for the preparation thereof and their use |
| CA2403790C (en) * | 2000-01-18 | 2011-09-27 | Nereus Pharmaceuticals, Inc. | A cell division inhibitor and a production method thereof |
| NZ522568A (en) * | 2000-06-22 | 2004-12-24 | Pfizer Prod Inc | Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| BR0214606A (pt) * | 2001-11-30 | 2004-09-14 | Pfizer Prod Inc | Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal |
| AP2004003059A0 (en) * | 2001-12-12 | 2004-06-30 | Pfizer Prod Inc | Salt forms of E-2-methoxy-N-(3-(4-(3-methyl-pyridin-3-yloxyl)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| IL161908A0 (en) * | 2001-12-12 | 2005-11-20 | Pfizer Prod Inc | Quinazoline derivatives for the treatment of abnormal cell growth |
-
2003
- 2003-12-08 EP EP03813249A patent/EP1575592A1/de not_active Withdrawn
- 2003-12-08 KR KR1020057011285A patent/KR20050085749A/ko not_active Ceased
- 2003-12-08 AU AU2003303045A patent/AU2003303045A1/en not_active Abandoned
- 2003-12-08 JP JP2004560067A patent/JP2006513179A/ja active Pending
- 2003-12-08 CN CNA2003801069555A patent/CN1729001A/zh active Pending
- 2003-12-08 RU RU2005119172/04A patent/RU2005119172A/ru not_active Application Discontinuation
- 2003-12-08 BR BR0317433-6A patent/BR0317433A/pt not_active IP Right Cessation
- 2003-12-08 PL PL377686A patent/PL377686A1/pl not_active Application Discontinuation
- 2003-12-08 MX MXPA05006335A patent/MXPA05006335A/es unknown
- 2003-12-08 WO PCT/IB2003/005826 patent/WO2004054585A1/en not_active Ceased
- 2003-12-08 CA CA002510323A patent/CA2510323A1/en not_active Abandoned
- 2003-12-10 PE PE2003001246A patent/PE20040905A1/es not_active Application Discontinuation
- 2003-12-16 GT GT200300286A patent/GT200300286A/es unknown
- 2003-12-16 AR ARP030104645A patent/AR042480A1/es unknown
- 2003-12-16 US US10/737,691 patent/US20040254204A1/en not_active Abandoned
- 2003-12-17 NL NL1025044A patent/NL1025044C2/nl not_active IP Right Cessation
- 2003-12-17 PA PA20038592801A patent/PA8592801A1/es unknown
- 2003-12-17 TW TW092135744A patent/TW200424190A/zh unknown
-
2005
- 2005-05-23 ZA ZA200504147A patent/ZA200504147B/en unknown
- 2005-07-18 NO NO20053483A patent/NO20053483L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050085749A (ko) | 2005-08-29 |
| NL1025044A1 (nl) | 2004-06-21 |
| RU2005119172A (ru) | 2006-01-20 |
| BR0317433A (pt) | 2005-11-16 |
| AR042480A1 (es) | 2005-06-22 |
| AU2003303045A1 (en) | 2004-07-09 |
| CA2510323A1 (en) | 2004-07-01 |
| NO20053483D0 (no) | 2005-07-18 |
| TW200424190A (en) | 2004-11-16 |
| ZA200504147B (en) | 2006-07-26 |
| PE20040905A1 (es) | 2005-01-18 |
| NL1025044C2 (nl) | 2005-02-15 |
| GT200300286A (es) | 2004-08-13 |
| PA8592801A1 (es) | 2004-07-26 |
| WO2004054585A1 (en) | 2004-07-01 |
| MXPA05006335A (es) | 2005-08-26 |
| CN1729001A (zh) | 2006-02-01 |
| JP2006513179A (ja) | 2006-04-20 |
| US20040254204A1 (en) | 2004-12-16 |
| EP1575592A1 (de) | 2005-09-21 |
| PL377686A1 (pl) | 2006-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051303L (no) | Nye benzoimidazolderivater nyttige som antiproliferative midler | |
| WO2004056786A3 (en) | Pyrimidine derivates for the treatment of abnormal cell growth | |
| DK1029853T3 (da) | Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler | |
| CA2413424A1 (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
| MY124390A (en) | Substituted bicyclic derivatives useful as anticancer agents | |
| NO20055143L (no) | Doseringsformer innbefattende AG013736 | |
| WO2006067614A3 (en) | Heteroaromatic derivatives useful as anticancer agents | |
| CA2392973A1 (en) | Benzoimidazole derivatives useful as antiproliferative agents | |
| NO20062692L (no) | Heterosykliske MEK inhibitorer og fremgangsmater for anvendelse derav | |
| DE69923849D1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
| NO20050016L (no) | Difenylazetidinonderivater for behandling av forstyrrelser i lipid metabolismen | |
| NO20062689L (no) | Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer | |
| NO20062370L (no) | Amidderivater | |
| NO20076196L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
| NO20082338L (no) | Pyrimidinderivater for behandling av avvikende cellevekst | |
| NO20061432L (no) | N3 alkylerte benzimidazolederivater som MEK-inhibitorer | |
| NO20045103L (no) | Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse | |
| WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
| NO20076138L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
| DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
| NO20076137L (no) | Nye 2-azetidinonderivater og deres anvendelse som kolestrolabsorpsjonsinhibitorer for behandling av hyperlipidemi | |
| NO20015172L (no) | 1-metyl-erytromycin-derivater | |
| AU1025795A (en) | Prolineamide derivatives | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |